Chemoinformaics analysis of (3R,4S,5R)-3,4,5-Trihydroxy-1-cyclohexene-1- carboxylic acid
Molecular Weight | 174.152 | nRot | 1 |
Heavy Atom Molecular Weight | 164.072 | nRig | 8 |
Exact Molecular Weight | 174.053 | nRing | 1 |
Solubility: LogS | -0.307 | nHRing | 0 |
Solubility: LogP | -1.541 | No. of Aliphatic Rings | 1 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
nHA | 4 | APOL | 22.3679 |
nHD | 4 | BPOL | 10.9001 |
QED | 0.462 |
Synth | 3.683 |
Natural Product Likeliness | 2.101 |
NR-PPAR-gamma | 0.023 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.137 |
HIA | 0.267 |
CACO-2 | -5.809 |
MDCK | 0.00144417 |
BBB | 0.845 |
PPB | 0.194358 |
VDSS | 0.334 |
FU | 0.684464 |
CYP1A2-inh | 0.006 |
CYP1A2-sub | 0.047 |
CYP2c19-inh | 0.019 |
CYP2c19-sub | 0.054 |
CYP2c9-inh | 0.003 |
CYP2c9-sub | 0.861 |
CYP2d6-inh | 0.007 |
CYP2d6-sub | 0.136 |
CYP3a4-inh | 0.005 |
CYP3a4-sub | 0.007 |
CL | 3.591 |
T12 | 0.917 |
hERG | 0.009 |
Ames | 0.029 |
ROA | 0.044 |
SkinSen | 0.047 |
Carcinogencity | 0.019 |
EI | 0.353 |
Respiratory | 0.035 |
NR-Aromatase | 0.002 |
Antiviral | No |
Prediction | 0.922706 |